Smallpox Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Smallpox is an acute contagious infection caused by the Variola virus. Symptoms include fever, malaise, headache, prostration, severe back pain, abdominal pain, and vomiting. This is followed by the development of rashes on the face, hands, forearms, and trunk. Lesions develop in the mucous membranes of the nose and mouth which ulcerate, releasing large amounts of virus into the mouth and throat. Treatment includes medications such as antiviral and lifestyle modification.
The Smallpox drugs in development market research report provide comprehensive information on the therapeutics under development for Smallpox, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects.
Key Targets in the Smallpox Pipeline Products Market
The key targets in the Smallpox pipeline products market are p37 Envelope Protein, 2019 Novel corona Virus Spike Glycoprotein, and DNA.
Smallpox Pipeline Products Analysis Market by Targets
For more target insights, download a free report sample
Key Mechanisms of Action in the Smallpox Pipeline Products Market
The key mechanisms of action in the Smallpox pipeline products market are p37 Envelope Protein Inhibitor, 2019 Novel corona Virus Spike Glycoprotein Inhibitor, and DNA Synthesis Inhibitor.
Smallpox Pipeline Products Market Analysis by Mechanism of Actions
For more mechanism of actions insights, download a free report sample
Key Routes of Administration in the Smallpox Pipeline Products Market
The key routes of administration in the Smallpox pipeline products market are intravenous, topical, oral, intradermal, and subcutaneous.
Smallpox Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the Smallpox Pipeline Products Market
The key molecule types in the Smallpox pipeline products market are small molecule, live attenuated vaccine, recombinant vector vaccine, DNA vaccine, monoclonal antibody, subunit vaccine, and vaccine.
Smallpox Pipeline Products Market Analysis by Molecule Type
For more molecule type insights, download a free report sample
Major Companies in the Smallpox Pipeline Products Market
The major companies in the Smallpox pipeline products market are SIGA Technologies Inc, Tonix Pharmaceuticals Holding Corp, AlphaVax Inc, Bavarian Nordic A/S, BioFactura Inc, EpiVax Inc, HK inno.N Corp, and Viraze.
Smallpox Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
Market Report Overview
Key targets | p37 Envelope Protein, 2019 Novel corona Virus Spike Glycoprotein, and DNA |
Key mechanism of action | p37 Envelope Protein Inhibitor, 2019 Novel corona Virus Spike Glycoprotein Inhibitor, and DNA Synthesis Inhibitor |
Key routes of administration | Intravenous, Topical, Oral, Intradermal, and Subcutaneous |
Key molecule type | Small Molecule, Live Attenuated Vaccine, Recombinant Vector Vaccine, DNA Vaccine, Monoclonal Antibody, Subunit Vaccine, and Vaccine |
Major companies | SIGA Technologies Inc, Tonix Pharmaceuticals Holding Corp, AlphaVax Inc, Bavarian Nordic A/S, BioFactura Inc, EpiVax Inc, HK inno.N Corp, and Viraze |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Smallpox (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Smallpox (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Smallpox (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Smallpox (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Smallpox (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Smallpox (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Smallpox (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Bavarian Nordic A/S
BioFactura Inc
EpiVax Inc
HK inno.N Corp
SIGA Technologies Inc
Tonix Pharmaceuticals Holding Corp
Viraze
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Smallpox pipeline products market?
The key targets in the Smallpox pipeline products market are p37 Envelope Protein, 2019 Novel corona Virus Spike Glycoprotein, and DNA.
-
What are the key mechanisms of action in the Smallpox pipeline products market?
The key mechanisms of action in the Smallpox pipeline products market are p37 Envelope Protein Inhibitor, 2019 Novel corona Virus Spike Glycoprotein Inhibitor, and DNA Synthesis Inhibitor.
-
What are the key routes of administration in the Smallpox pipeline products market?
The key routes of administration in the Smallpox pipeline products market are intravenous, topical, oral, intradermal, and subcutaneous.
-
What are the key molecule types in the Smallpox pipeline products market?
The key molecule types in the Smallpox pipeline products market are small molecule, live attenuated vaccine, recombinant vector vaccine, DNA vaccine, monoclonal antibody, subunit vaccine, and vaccine.
-
Which are the major companies in the Smallpox pipeline products market?
The major companies in the Smallpox pipeline products market are SIGA Technologies Inc, Tonix Pharmaceuticals Holding Corp, AlphaVax Inc, Bavarian Nordic A/S, BioFactura Inc, EpiVax Inc, HK inno.N Corp, and Viraze.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.